Russell, N., Burnett, A. K., Hills, R. K., Kell, J., Cavenagh, J., Kjeldsen, L., McMullin, M.-F., Cahalin, P., Dennis, M., Friis, L., Thomas, I. F., Milligan, D., & Clark, R. E. (2015). A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients. Blood, 125(25), 3678-3885. https://doi.org/10.1182/blood-2015-01-623447